Supplement funding: Implemting comprehensive PMTCT & HIV prevention for South African couples

STATUS: Completed
PROJECT LEADER:Peltzer, KF (Prof. Karl)
OTHER TEAM MEMBERS: Nyawane, CL (Ms Lebo), Mashigwana, FR (Ms Fikile), Sifunda, SW (Prof. Sibusiso), Ramlagan, S (Dr Shandir)
DEPARTMENT RESPONSIBLE: Human and Social Capabilities (HSC)


The evidence base for the use of ARVs to prevent mother to child transmission (PMTCT) to enhance infant and maternal health is extensive. In South Africa (SA), although PMTCT programs have been made available as a matter of national policy, reductions in MTCT have been, for the most part, greatest in urbanized areas, while rural areas have maintained unacceptably high levels of MTCT [1]. In rural South Africa, one third of HIV+ pregnant women in antenatal care at community health centers did not take full advantage of available PMTCT services in 2010 [2]. In 2011, Mpumalanga Province had the highest rates of HIV in the country (36.7%) and rates of infant HIV incidence in rural clinics ranged up to 50%. Rates of PMTCT uptake in the Province have been among the lowest in South Africa (69%).